6173 results
Cited 4 times since 2004 (0.2 per year)
source: EuropePMC
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology,
Volume 5, Issue 3, 1 1 2004, Pages 231-236
Aortic valve regurgitation due to cusp aneurysm: a case report.
Scholte AJ, Agema WR, Poldermans D, Somer ST, Holman ER, van der Wall EE, Bax JJ
Two-dimensional echocardiography is a valuable tool in visualizing and monitoring aortic valve and root abnormalities. We present a rare case of a patient with massive aortic regurgitation due to cusp aneurysm, which was accurately diagnosed by echocardiography and treated by valve replacement. A complicated course with recurrent aneurysms of the aortic wall after aortic valve replacement was remarkable in this case. Although different possible etiologies could not be determined, endocarditis an...
Abstract
Cited 1 times since 2004 (0 per year)
source: EuropePMC
The Annals of thoracic surgery,
Volume 77, Issue 6, 1 1 2004, Pages 2262-3; author reply 2263
Use of autologous arterial patches for tracheal reconstruction in young infants.
Hazekamp MG, Nijdam N
Abstract
Cited 57 times since 2004 (2.7 per year)
source: EuropePMC
Circulation research,
Volume 95, Issue 1, 20 3 2004, Pages 58-66
Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo.
van Weel V, Deckers MM, Grimbergen JM, van Leuven KJ, Lardenoye JH, Schlingemann RO, van Nieuw Amerongen GP, van Bockel JH, van Hinsbergh VW, Quax PH
Therapeutic angiogenesis using vascular endothelial growth factor (VEGF) is considered a promising new therapy for patients with arterial obstructive disease. Clinical improvements observed consist of improved muscle function and regression of rest pain or angina. However, direct evidence for improved vascularization, as evaluated by angiography, is weak. In this study, we report an angiogenesis-independent effect of VEGF on ischemic skeletal muscle, ie, upregulation of myoglobin after VEGF trea...
Abstract
Cited 3 times since 2004 (0.1 per year)
source: EuropePMC
Intensive care medicine,
Volume 30, Issue 7, 4 1 2004, Pages 1370-1376
Transcardiac conductance for continuous measurement of left ventricular volume: validation vs. angiography in patients.
Staal EM, Baan J, Jukema JW, van der Wall EE, Steendijk P
Objective: To test the feasibility of the transcardiac conductance (TCC) method for continuous, on-line measurement of absolute left ventricular (LV) volume and to validate the method by comparison with biplane angiography. Design and setting: Prospective clinical feasibility and validation study in a cardiac catheterization laboratory in a university hospital. Patients and interventions: Ten patients scheduled for electrophysiological studies ( n=5), percutaneous transluminal coronary angioplas...
Abstract
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 12, Issue 5, 1 1 2004, Pages 255-256
Recommendations for pacemaker implantation for the treatment of atrial tachyarrhythmias and resynchronisation therapy for heart failure.
Wijffels MC, Bootsma M, van Erven L, Zeppenfeld K, Schalij MJ, van Hemel NM
Abstract
Cited 13 times since 2004 (0.6 per year)
source: EuropePMC
Pathologie-biologie,
Volume 52, Issue 4, 1 1 2004, Pages 186-195
Genetic predictive factors in restenosis.
Monraats PS, R P Agema W, Jukema JW
Restenosis is still the main drawback of percutaneous transluminal coronary angioplasty (PTCA). It is thought to be a multifactorial process where recoil of the vessel, neointimal proliferation and thrombus formation are thought to play a role. Until now it has proven difficult to predict restenosis on clinical and procedural grounds, however, genetic epidemiology might provide more insights. In this review several genetic variables, i.e. polymorphisms that were determined in relation to resteno...
Abstract
Cited 12 times since 2004 (0.6 per year)
source: EuropePMC
European journal of pharmacology,
Volume 491, Issue 2-3, 1 1 2004, Pages 173-179
Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocarditis: effects of carvedilol and metoprolol.
Tschöpe C, Westermann D, Steendijk P, Noutsias M, Rutschow S, Weitz A, Schwimmbeck PL, Schultheiss HP, Pauschinger M
Background: Carvedilol, a vasodilating nonselective beta-adrenoceptor antagonist, but not metoprolol, a selective beta1-adrenoceptor antagonist, has been shown to increase the production of cardiac antiinflammatory cytokines in experimental myocarditis. However, the hemodynamic consequences of these differences had not been investigated until today. Therefore, we determined the effects of carvedilol and metoprolol on left ventricular function in a murine model of coxsackievirus B3 (CVB3)-induced...
Abstract
Cited 1 times since 2004 (0 per year)
source: EuropePMC
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 12, Issue 5, 1 1 2004, Pages 214-222
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 2.
Hoogsteen J, Bennekers JH, van der Wall EE, van Hemel NM, Wilde AA, Crijns HJ, Gorgels AP, Smeets JL, Hauer RN, Jordaens JL, Schalij MJ
Confronted with a competitive or recreational athlete, the physician has to discriminate between benign, paraphysiological and pathological arrhythmias. Benign arrhythmias do not represent a risk for SCD, nor do they induce haemodynamic consequences during athletic activities. These arrhythmias are not markers for heart disease. Paraphysiological arrhythmias are related to athletic performance. Long periods of endurance training induce changes in rhythm, conduction and repolarisation. These chan...
Abstract
Cited 47 times since 2004 (2.2 per year)
source: EuropePMC
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation,
Volume 13, Issue 4, 1 1 2004, Pages 735-745
A cardiac-specific health-related quality of life module for young adults with congenital heart disease: development and validation.
Kamphuis M, Zwinderman KH, Vogels T, Vliegen HW, Kamphuis RP, Ottenkamp J, Verloove-Vanhorick SP, Bruil J
This study represents the development and validation of a cardiac-specific module of the generic health-related quality of life (HRQoL) instrument, the TAAQOL (TNO/AZL Adult Quality Of Life), for young adults with congenital heart disease (CHD). Items were selected based on literature, an explorative previous study in CHD patients, interviews with patients, and the advice of experts. The newly developed Congenital Heart Disease-TNO/AZL Adult Quality of Life (CHD-TAAQOL) was tested in 156 patient...
Abstract
Cited 252 times since 2004 (12 per year)
source: EuropePMC
Journal of cardiovascular electrophysiology,
Volume 15, Issue 5, 1 1 2004, Pages 544-549
Relationship between QRS duration and left ventricular dyssynchrony in patients with end-stage heart failure.
Bleeker GB, Schalij MJ, Molhoek SG, Verwey HF, Holman ER, Boersma E, Steendijk P, Van Der Wall EE, Bax JJ
Introduction: Patients with end-stage heart failure and a wide QRS complex are considered candidates for cardiac resynchronization therapy (CRT). However, 20% to 30% of patients do not respond to CRT. Lack of left ventricular dyssynchrony may explain the nonresponse. Accordingly, we evaluated the presence of left ventricular dyssynchrony using tissue Doppler imaging (TDI) in 90 consecutive patients with heart failure. Methods and results: Ninety patients with severe heart failure (left ventricul...
Abstract
Cited 14 times since 2004 (0.7 per year)
source: EuropePMC
Heart rhythm,
Volume 1, Issue 1, 1 1 2004, Pages 51-57
Standardized screening and treatment of patients with life-threatening arrhythmias: the Leiden out-of-hospital cardiac arrest evaluation study.
van der Burg AE, Bax JJ, Boersma E, van Erven L, Bootsma M, van der Wall EE, Schalij MJ
Objectives: The aim of this study was to evaluate the effect of a systematic screening/treatment protocol on outcome in patients after aborted sudden death. Background: Patients after aborted sudden death are at high risk for recurrent events. In this regard, systematic screening is mandatory to reveal the underlying etiology, to detect and subsequently treat reversible causes, and to establish patient-tailored antiarrhythmic treatment. Methods: A total of 417 consecutive patients after aborted...
Abstract
Cited 9 times since 2004 (0.4 per year)
source: EuropePMC
The American journal of cardiology,
Volume 93, Issue 10, 1 1 2004, Pages 1298-1302
Anatomical observations of the pulmonary veins with intracardiac echocardiography and hemodynamic consequences of narrowing of pulmonary vein ostial diameters after radiofrequency catheter ablation of atrial fibrillation.
Jongbloed MR, Bax JJ, Zeppenfeld K, van der Wall EE, Schalij MJ
Intracardiac echocardiography was used to explore pulmonary venous (PV) anatomy and to monitor PV stenosis in 31 patients referred for radiofrequency catheter ablation at PV ostia. Interindividual variations in PV anatomy and insertion in the left atrium were observed. Narrowing of PV ostia after radiofrequency catheter ablation did not produce significant hemodynamic changes.
Abstract
Cited 108 times since 2004 (5.1 per year)
source: EuropePMC
The Journal of experimental medicine,
Volume 199, Issue 10, 1 1 2004, Pages 1409-1420
CD8 T cell recognition of endogenously expressed epstein-barr virus nuclear antigen 1.
Lee SP, Brooks JM, Al-Jarrah H, Thomas WA, Haigh TA, Taylor GS, Humme S, Schepers A, Hammerschmidt W, Yates JL, Rickinson AB, Blake NW
The Epstein-Barr virus (EBV) nuclear antigen (EBNA)1 contains a glycine-alanine repeat (GAr) domain that appears to protect the antigen from proteasomal breakdown and, as measured in cytotoxicity assays, from major histocompatibility complex (MHC) class I-restricted presentation to CD8+ T cells. This led to the concept of EBNA1 as an immunologically silent protein that although unique in being expressed in all EBV malignancies, could not be exploited as a CD8 target. Here, using CD8+ T cell clon...
Abstract
Cited 110 times since 2004 (5.2 per year)
source: EuropePMC
European heart journal,
Volume 25, Issue 10, 1 1 2004, Pages 815-836
Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology.
Underwood SR, Bax JJ, vom Dahl J, Henein MY, Knuuti J, van Rossum AC, Schwarz ER, Vanoverschelde JL, van der Wall EE, Wijns W, Study Group of the European Society of Cardiology
This report of an ESC Study Group reviews current knowledge on myocardial hibernation and relevant imaging techniques, and provides an algorithm for investigation and management when a patient presents with ischaemic left ventricular dysfunction. It covers the definitions of myocardial viability, stunning and hibernation, it reviews the morphological findings in hibernation and it describes relevant clinical settings. The imaging and other techniques that are reviewed are electrocardiography, po...
Abstract
Cited 39 times since 2004 (1.9 per year)
source: EuropePMC
Basic research in cardiology,
Volume 99, Issue 5, 16 3 2004, Pages 351-359
Left ventricular pressure-volume measurements in mice: comparison of closed-chest versus open-chest approach.
Lips DJ, van der Nagel T, Steendijk P, Palmen M, Janssen BJ, van Dantzig JM, de Windt LJ, Doevendans PA
Objective: We investigated whether in vivo closed-chest left ventricular pressure-volume measurements would yield similar values for LV hemodynamics compared with open-chest PV measurements under several anesthetics. Methods: The right common carotid of C57Bl/6 mice was cannulated with a combined pressure-conductance catheter and inserted retrogradely into the left ventricle in the closed-chest model. The open-chest model consisted of an abdominal approach involving the opening of the thoracic c...
Abstract
Cited 299 times since 2004 (14.2 per year)
source: EuropePMC
Annals of the rheumatic diseases,
Volume 63, Issue 4, 1 1 2004, Pages 373-381
Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages.
Vossenaar ER, Radstake TR, van der Heijden A, van Mansum MA, Dieteren C, de Rooij DJ, Barrera P, Zendman AJ, van Venrooij WJ
Background: Antibodies directed to proteins containing the non-standard amino acid citrulline, are extremely specific for rheumatoid arthritis (RA). Peptidylcitrulline can be generated by post-translational conversion of arginine residues. This process, citrullination, is catalysed by a group of calcium dependent peptidylarginine deiminase (PAD) enzymes. Objective: To investigate the expression and activity of four isotypes of PAD in peripheral blood and synovial fluid cells of patients with RA....
Abstract
Cited 69 times since 2004 (3.3 per year)
source: EuropePMC
The American journal of cardiology,
Volume 93, Issue 7, 1 1 2004, Pages 860-863
Comparison of benefits from cardiac resynchronization therapy in patients with ischemic cardiomyopathy versus idiopathic dilated cardiomyopathy.
Molhoek SG, Bax JJ, van Erven L, Bootsma M, Boersma E, Steendijk P, van der Wall EE, Schalij MJ
Cardiac resynchronization therapy (CRT) is a recently introduced therapeutic option for patients with severe heart failure and intraventricular conduction disturbances. However, it is estimated that 20% to 30% of patients may not respond to CRT. Patients with ischemic cardiomyopathy (IC) may respond less favorably to CRT compared with patients with idiopathic dilated cardiomyopathy (IDC). Accordingly, the beneficial effects of CRT were evaluated in 2 subsets of patients (IC and IDC). Seventy-fou...
Abstract
Cited 5 times since 2004 (0.2 per year)
source: EuropePMC
The international journal of cardiovascular imaging,
Volume 20, Issue 2, 1 1 2004, Pages 113-116
Thrombus in the left atrial appendage detected by intracardiac echocardiography.
Jongbloed MR, Bax JJ, van der Wall EE, Schalij MJ
Radiofrequency catheter ablation (RFCA) at the ostium of the pulmonary veins can potentially cure atrial fibrillation. Left-sided ablation procedures may carry a risk of thrombo-embolic events. Emboli from intracardiac thrombus originate from the left atrial appendage (LAA) in a substantial number of patients. The presence of spontaneous echo contrast in the left atrium (LA) and LAA peak emptying flow < or = 20 cm/s are also significantly related to thrombo-embolic events. Evaluation of the a...
Abstract
Cited 15 times since 2004 (0.7 per year)
source: EuropePMC
Critical care medicine,
Volume 32, Issue 4, 1 1 2004, Pages 1087-1089
Right ventricular function and failure: methods, models, and mechanisms.
Steendijk P
Abstract
Cited 5 times since 2004 (0.2 per year)
source: EuropePMC
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
Volume 12, Issue 4, 1 1 2004, Pages 157-164
Recommendations and cardiological evaluation of athletes with arrhythmias: Part 1.
Hoogsteen J, Bennekers JH, van der Wall EE, van Hemel NM, Wilde AA, Crijns HJ, Gorgels AP, Smeets JL, Hauer RN, Jordaens JL, Schalij MJ
Besides the consensus meeting in Amersfoort in 1988 and the Bethesda conference in 1994 recommendations are not available in the Netherlands for screening and evaluation of athletes with cardiac arrhythmias. Guidelines for competitive athletes with cardiac arrhythmias in the United States and Italy were published in 2000. In 1998 Estes et al. published the most important opinions on sudden cardiac death, screening and evaluation of athletes and arrhythmias. This study addresses the physiological...
Abstract
